Europe · Markets & Finance · L'Agefi Suisse

Un collyre d’Alcon autorisé aux Etats-Unis

Published by L'Agefi Suisse · Switzerland 1 d ago

L’autorité sanitaire américaine (FDA) a homologué les gouttes ophtalmiques Brytly, un traitement contre les rougeurs oculaires disponible sans ordonnance.

Read the full article on L'Agefi Suisse Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (agefi.com)

Also worth reading

This is Money

Are you considering buying Premium Bonds? This is the best time to snap them up - and why I expect there's good news on the way: SYLVIA MORRIS

Financial Times

Un collyre d’Alcon autorisé aux Etats-Unis

Share

Also worth reading

Are you considering buying Premium Bonds? This is the best time to snap them up - and why I expect there's good news on the way: SYLVIA MORRIS

Trump exempts Russia from further sanctions mandated by new law

These are the best literary hotels in Europe

Exotic species appear off California thanks to an unusually strong El Niño

BOJ may need to tighten faster if inflation beats forecast, IMF says

Celestia jumps 57% to 11-month high as 7 altcoins beat the market